APA (7th ed.) Citation

I, F. v. R., R, B., AT, D., C, T., M, H., M, M., . . . K, U. (2026). Genetically engineered organs for early reporting of transplant rejection. Molecular therapy : the journal of the American Society of Gene Therapy, 34(2), 801. https://doi.org/10.1016/j.ymthe.2025.10.024

Chicago Style (17th ed.) Citation

I, Filz von Reiterdank, et al. "Genetically Engineered Organs for Early Reporting of Transplant Rejection." Molecular Therapy : The Journal of the American Society of Gene Therapy 34, no. 2 (2026): 801. https://doi.org/10.1016/j.ymthe.2025.10.024.

MLA (9th ed.) Citation

I, Filz von Reiterdank, et al. "Genetically Engineered Organs for Early Reporting of Transplant Rejection." Molecular Therapy : The Journal of the American Society of Gene Therapy, vol. 34, no. 2, 2026, p. 801, https://doi.org/10.1016/j.ymthe.2025.10.024.